Skip to content

Relevance of an Adapted and Supervised Physical Activity Program in Fibromyalgia Patients. The FIMOUV 1 Study.

Relevance of an Adapted and Supervised Physical Activity Program in Fibromyalgia Patients. The FIMOUV 1 Study. Interventional, Controlled, Randomized, Open Study of an Original Outpatient Management.

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03736733
Acronym
FIMOUV 1
Enrollment
60
Registered
2018-11-09
Start date
2018-11-15
Completion date
2021-06-11
Last updated
2022-09-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Fibromyalgia, Physical Activity

Keywords

sedentary time

Brief summary

Fibromyalgia affects 2 to 5% of adults in the general population. Patients describe a combination of symptoms centred around fatigue not induced by exercise and not relieved by rest. The diagnosis of fibromyalgia is self-perpetuating by the deconditioning, consequence of a reduced muscle mass due to inactivity and periods of prolonged rest. Thus, it seems fundamental to develop other non-drug approaches: among them, adapted physical activity is recommended by most learned societies because of a good level of evidence (Level 1, Grade A). The question remains, however, whether simple advice to resume physical activity is sufficient (routine care with medical assessment at 3 months) or whether a physical activity supervised inside and outside the hospital is not more relevant.

Interventions

OTHERphysical activity program

Two weekly exercise sessions at the university hospital of St-Etienne for 1 month then relay outside in a sports association or club certified Sports Health in the Loire (42) or Haute-Loire (43) for 2 months.

Advice and recommendations of physical activity at home (= current clinical practice, from 1 to 3 sessions per week in autonomy).

Sponsors

Centre Hospitalier Universitaire de Saint Etienne
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
OTHER
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Patient lived in t Loire (42) or Haute-Loire (43) * Patient diagnosed with fibromyalgia according to ACR (American College of rheumatology) criteria (total score WPI (Widespread Pain Index) + SS (Severity Scale) ) ≥ 13 * French writing and speaking * Sedentary or low level of activity (less than 2 hours of regular physical activity per week at the time of inclusion) * Signature of informed consent

Exclusion criteria

* Cardiac or respiratory diseases that contraindicate the practice of physical activity * Significant co-morbidities that contraindicate the practice of physical activity: associated cardiac pathologies (severe rhythm disorders such as rapid atrial fibrillation), respiratory pathologies (severe obstructive or severe respiratory insufficiency), disabling joint pathologies (knee osteoarthritis or osteoarthritis of the hip) training on a treadmill or on a high intensity bike). * Impossibility of submitting to the medical monitoring of the program for geographical, social or psychological reason

Design outcomes

Primary

MeasureTime frameDescription
Assessment of the impact of a 3-month programat 3 monthsHealth status assessed by the PGIC = Patient Global Impression of Change. interpretation : 0= no change, 7= clear improvement, 5= better).

Secondary

MeasureTime frameDescription
Quality of sleepat 3 monthsassessed by the Pittsburgh. The questionnaire includes 19 self-assessment questions and 5 questions for the spouse or roommate (if any). Only self-assessment questions are included in the score. The 19 self-assessment questions combine to give 7 components of the score with each component receiving a score of 0 to 3. In all cases, a score of 0 indicates that there is no difficulty while a score of 3 indicates the existence of severe difficulties. The 7 components of the score add up to give an overall score from 0 to 21 points, 0 meaning that there is no difficulty, and 21 indicating on the contrary major difficulties.
Anxiety and Depressionat 3 monthsassessed by the Hospital Anxiety and Depression Scale (HADS) : An overall score of 19 or more indicates a major depressive episode. An overall score of 13 corresponds to adjustment disorders and minor depression.
pain catastrophizingat 3 monthsassessed by the PCS (pain catastrophizing scale) assessing catastrophism : there are thirteen statements describing different thoughts and emotions that may be associated with pain. the person must indicate how painful these thoughts and emotions are. From 0= not at all to 4 = all the time
pain evaluationat 3 monthsassessed by analog visual evaluation of pain (0= no pain and 10 = very painful)
muscle powerat 3 monthsevaluated by dynamometry on a stress platform (arms and legs) and by a pocket dynamometer.
muscular enduranceat 3 monthsevaluated by dynamometry on a stress platform (arms and legs).
gas exchange measurementat 3 monthsevaluated during a stress test
quantification of physical activity in meter-h/weekat 3 monthsevaluated by the APAQ : Adult Physical Activity Questionnaire
fatigueat 3 monthsassessed by Fatigue Severity Scale. This is a short questionnaire of 9 questions to which the patient answers on a scale from 1 to 7. Simply add the scores and divide by 9 - you get a result on 7 points. The higher the result, the greater the fatigue. Several studies speak of a threshold at 5.5
daily energy expenditureat 3 monthsevaluated by actimetry
time of physical activityat 3 monthsevaluated by actimetry
physical inactivityat 3 monthsevaluated by actimetry
patient adherenceat 3, 6 and 12 monthsnumber of sessions performed
Direct medical costsat 3, 6 and 12 monthsconsultations, examinations, hospitalizations in euros
Direct non-medical costsat 3, 6 and 12 monthstransport
Cost of lost productivityat 3, 6 and 12 monthstime not worked
sedentary times in hours/dayat 3 monthsevaluated by the APAQ : Adult Physical Activity Questionnaire

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026